![]() | |
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C26H19FN2O |
Molar mass | 394.449 g·mol−1 |
3D model (JSmol) | |
| |
|
FDU-NNE1 (also known as FDU-NNEI and FDU-MN-24) is an indole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug.[1][2] Given the known metabolic liberation (and presence as an impurity) of amantadine in the related compound APINACA, it is suspected that metabolic hydrolysis of the amide group of FDU-NNE1 will release 1-naphthylamine, a known carcinogen.
See also
[edit]References
[edit]- ^ "FDU-NNEI". Cayman Chemical. Retrieved 23 July 2015.
- ^ Uchiyama N, Shimokawa Y, Kikura-Hanajiri R, Demizu Y, Goda Y, Hakamatsuka T (February 2015). "N-OH-EDMA, and a cathinone derivative dimethoxy-α-PHP, newly identified in illegal products". Forensic Toxicology. 33 (2): 244–259. doi:10.1007/s11419-015-0268-7. PMC 4525202. PMID 26257833.